Previous reports have also indicated Bat3, which controls acetylation and thus activation of p53, also colocalizes with HLA I on the surface of tumor and dendritic cells, where it serves as a ligand for NKp30 [20], [21], [31]. Here, NCR3 is linked to neoplasm.